Crosslinks has selected Tibco Spotfire enterprise analytics platform to power research analysis advancements across Europe in the field of bioinformatics.
Crosslinks aims to foster the scientific exchange of ideas between members of the bioinformatics community throughout Europe and address the industry's move towards a more diagnostic approach.
Tibco Spotfire enterprise analytics platform will provide a fundamental tool for the sharing of research in areas such as genomics and proteomics analysis between academic organisations through streamlined and easy-to-use analytics workflows.
Crosslinks is a spin-off from the Department of Bioinformatics at the Erasmus University Medical Center (Erasmus MC) in Rotterdam, The Netherlands.
Its services, solutions and technologies deal with large data sets for life-sciences companies and biomedical research.
Spotfire enterprise analytics platform will allow academic users in the field of bioinformatics to analyse a range of data in a flexible manner, providing summary information and visualisations at great speed.
Microarray experiments or, more generally, results from genomic experiments can be integrated with non-numerical data to facilitate target identification or patient stratification.
Under the terms of the new licence agreement, Crosslinks will work closely with scientists to provide training to users of Tibco Spotfire.
